ECS ramps up in-house range with launch of ‘value brand’ by Steve Jones and Martin Lane November 15, 2024November 21, 2024 ECS Botanics has joined the growing number of producers in releasing lower-priced medicine into the market. […]
ECS Botanics revenues rise again with retail strategy ‘growing strongly’ by Steve Jones October 23, 2024October 23, 2024
ECS Botanics secures rights to roll out Terphogz range in Germany, Australia and NZ by Martin Lane September 18, 2024September 18, 2024
ECS Botanics reports A$2m profit in ‘extremely positive year’ by Steve Jones August 28, 2024August 28, 2024
ODC faces renewed calls to monitor imports amid stockpiling concerns by Steve Jones August 15, 2024August 15, 2024
Full year revenue jumps 29% but ‘price pressure’ dents fourth quarter for ECS Botanics by Steve Jones July 29, 2024July 29, 2024
Indoor, glasshouse or outdoor growing? There’s room for all as industry aims to compete with the best by Steve Jones July 18, 2024July 18, 2024
Company news: ECS Botanics; Althea; InhaleRx; Neurotech International by Martin Lane and Steve Jones July 10, 2024July 11, 2024
ECS Botanics prepares for ‘massive shift’ towards retail strategy by Steve Jones May 29, 2024May 30, 2024
